Fig. 1From: Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite proteinDose-dependent changes in inhibition of parasite liver burden from seven independent studies. Dose versus log10 total flux achieved in mice receiving 600, 300, 100, 30, and 0 µg doses of AB311 is shown. Curves represent the dose–response relationship estimated using 4PL models for each experiment and points represent the observed flux for each mouse. Mean and 95% CI for estimated ID50s, the dose by which liver burden is reduced 50% between the upper and lower bounds of measurement, are shown for each studyBack to article page